开云app官网登录入口网页版-官方正版

#多烯紫杉醇#

18篇内容 | 1140人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1417366, encodeId=555c141e366e8, content=<a href='/topic/show?id=28ca43332b5' target=_blank style='color:#2F92EE;'>#多烯紫杉醇#</a>, objectTitle=Prostate Cancer：纳米体多烯紫杉醇脂悬液在转移去势抵抗性前列腺癌中的多中心、回顾性疗效和安全性研究, objectType=article, longId=205674, objectId=19872056e42f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19872056e42f, replyNumber=0, likeNumber=75, createdTime=2021-01-14, rootId=0, userName=zhangmingxiang, userId=63eb3265522, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19872056e42f, moduleTitle=Prostate Cancer：纳米体多烯紫杉醇脂悬液在转移去势抵抗性前列腺癌中的多中心、回顾性疗效和安全性研究, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=19872056e42f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417365, encodeId=a682141e36561, content=<a href='/topic/show?id=28ca43332b5' target=_blank style='color:#2F92EE;'>#多烯紫杉醇#</a>, objectTitle=Brit J Cancer：雄激素受体信号削弱了多烯紫杉醇的疗效, objectType=article, longId=202140, objectId=2bc0202140a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2bc0202140a0, replyNumber=0, likeNumber=61, createdTime=2020-10-17, rootId=0, userName=zhangmingxiang, userId=63eb3265522, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2bc0202140a0, moduleTitle=Brit J Cancer：雄激素受体信号削弱了多烯紫杉醇的疗效, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=2bc0202140a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417364, encodeId=dabc141e36467, content=<a href='/topic/show?id=28ca43332b5' target=_blank style='color:#2F92EE;'>#多烯紫杉醇#</a>, objectTitle=Cancer Immunol Immunother：混合多肽疫苗组合多烯紫杉醇和地塞米松治疗去势抵抗性前列腺癌研究, objectType=article, longId=188409, objectId=717318840990, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=717318840990, replyNumber=0, likeNumber=85, createdTime=2020-02-21, rootId=0, userName=zhangmingxiang, userId=63eb3265522, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=717318840990, moduleTitle=Cancer Immunol Immunother：混合多肽疫苗组合多烯紫杉醇和地塞米松治疗去势抵抗性前列腺癌研究, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=717318840990)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417363, encodeId=06fe141e363b3, content=<a href='/topic/show?id=28ca43332b5' target=_blank style='color:#2F92EE;'>#多烯紫杉醇#</a>, objectTitle=Cell Death & Differentiation：去泛素化酶USP33能够抑制多烯紫杉醇诱导的细胞凋亡, objectType=article, longId=185524, objectId=39de18552480, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=39de18552480, replyNumber=0, likeNumber=64, createdTime=2020-01-02, rootId=0, userName=zhangmingxiang, userId=63eb3265522, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39de18552480, moduleTitle=Cell Death & Differentiation：去泛素化酶USP33能够抑制多烯紫杉醇诱导的细胞凋亡, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=39de18552480)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417362, encodeId=31bf141e3627e, content=<a href='/topic/show?id=28ca43332b5' target=_blank style='color:#2F92EE;'>#多烯紫杉醇#</a>, objectTitle=Brit J Cancer：重定位筛选鉴定了甲苯咪唑可作为临床候选药物协同多烯紫杉醇治疗前列腺癌, objectType=article, longId=185469, objectId=e624185469b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e624185469b0, replyNumber=0, likeNumber=67, createdTime=2020-01-01, rootId=0, userName=zhangmingxiang, userId=63eb3265522, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e624185469b0, moduleTitle=Brit J Cancer：重定位筛选鉴定了甲苯咪唑可作为临床候选药物协同多烯紫杉醇治疗前列腺癌, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=e624185469b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417361, encodeId=a80d141e361b1, content=<a href='/topic/show?id=28ca43332b5' target=_blank style='color:#2F92EE;'>#多烯紫杉醇#</a>, objectTitle=Oncogene：拮抗剂贝沙罗汀靶向TR4核受体能够增加前列腺癌对多烯紫杉醇的敏感性, objectType=article, longId=184301, objectId=1ec6184301de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ec6184301de, replyNumber=0, likeNumber=54, createdTime=2019-12-06, rootId=0, userName=zhangmingxiang, userId=63eb3265522, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ec6184301de, moduleTitle=Oncogene：拮抗剂贝沙罗汀靶向TR4核受体能够增加前列腺癌对多烯紫杉醇的敏感性, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=1ec6184301de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417360, encodeId=c9fb141e36019, content=<a href='/topic/show?id=28ca43332b5' target=_blank style='color:#2F92EE;'>#多烯紫杉醇#</a>, objectTitle=Ann Oncol：在低和高负担转移激素敏感性前列腺癌的激素治疗中加入多烯紫杉醇效果研究, objectType=article, longId=182375, objectId=14d91823e591, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14d91823e591, replyNumber=0, likeNumber=72, createdTime=2019-11-06, rootId=0, userName=zhangmingxiang, userId=63eb3265522, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14d91823e591, moduleTitle=Ann Oncol：在低和高负担转移激素敏感性前列腺癌的激素治疗中加入多烯紫杉醇效果研究, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=14d91823e591)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417359, encodeId=e473141e359fc, content=<a href='/topic/show?id=28ca43332b5' target=_blank style='color:#2F92EE;'>#多烯紫杉醇#</a>, objectTitle=Prostate Cancer P D：去势敏感性前列腺癌中醋酸阿比特龙与多烯紫杉醇治疗成本效益分析, objectType=article, longId=175788, objectId=811c1e5788de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=811c1e5788de, replyNumber=0, likeNumber=68, createdTime=2019-07-21, rootId=0, userName=zhangmingxiang, userId=63eb3265522, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=811c1e5788de, moduleTitle=Prostate Cancer P D：去势敏感性前列腺癌中醋酸阿比特龙与多烯紫杉醇治疗成本效益分析, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=811c1e5788de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417358, encodeId=d2fc141e358f5, content=<a href='/topic/show?id=28ca43332b5' target=_blank style='color:#2F92EE;'>#多烯紫杉醇#</a>, objectTitle=Prostate：靶向POH1能够抑制前列腺癌细胞生长和增强雄激素阻断治疗以多烯紫杉醇的抑制效果, objectType=article, longId=174683, objectId=796a1e4683e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=796a1e4683e3, replyNumber=0, likeNumber=68, createdTime=2019-06-30, rootId=0, userName=zhangmingxiang, userId=63eb3265522, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=796a1e4683e3, moduleTitle=Prostate：靶向POH1能够抑制前列腺癌细胞生长和增强雄激素阻断治疗以多烯紫杉醇的抑制效果, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=796a1e4683e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417357, encodeId=859a141e3573d, content=<a href='/topic/show?id=28ca43332b5' target=_blank style='color:#2F92EE;'>#多烯紫杉醇#</a>, objectTitle=J Clin Oncol：转移去势难治性前列腺癌黑人和白人患者中，多烯紫杉醇治疗总生存率研究, objectType=article, longId=157391, objectId=58a315e391ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58a315e391ea, replyNumber=0, likeNumber=63, createdTime=2019-01-06, rootId=0, userName=zhangmingxiang, userId=63eb3265522, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58a315e391ea, moduleTitle=J Clin Oncol：转移去势难治性前列腺癌黑人和白人患者中，多烯紫杉醇治疗总生存率研究, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=58a315e391ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417356, encodeId=35b0141e356d1, content=<a href='/topic/show?id=28ca43332b5' target=_blank style='color:#2F92EE;'>#多烯紫杉醇#</a>, objectTitle=Brit J Cancer：Apatorsen与多烯紫杉醇结合治疗与多烯紫杉醇单独治疗铂抵抗性转移尿路上皮癌的比较研究, objectType=article, longId=140374, objectId=91e81403e4fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=91e81403e4fd, replyNumber=0, likeNumber=78, createdTime=2018-06-10, rootId=0, userName=zhangmingxiang, userId=63eb3265522, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=91e81403e4fd, moduleTitle=Brit J Cancer：Apatorsen与多烯紫杉醇结合治疗与多烯紫杉醇单独治疗铂抵抗性转移尿路上皮癌的比较研究, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=91e81403e4fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417355, encodeId=9d32141e355f0, content=<a href='/topic/show?id=28ca43332b5' target=_blank style='color:#2F92EE;'>#多烯紫杉醇#</a>, objectTitle=BJU Int：去势难治性前列腺癌（CRPC）患者中，间断性多烯紫杉醇治疗与持续性多烯紫杉醇治疗比较, objectType=article, longId=136275, objectId=22441362e513, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22441362e513, replyNumber=0, likeNumber=106, createdTime=2018-04-25, rootId=0, userName=zhangmingxiang, userId=63eb3265522, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22441362e513, moduleTitle=BJU Int：去势难治性前列腺癌（CRPC）患者中，间断性多烯紫杉醇治疗与持续性多烯紫杉醇治疗比较, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=22441362e513)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417354, encodeId=a1e2141e3545d, content=<a href='/topic/show?id=28ca43332b5' target=_blank style='color:#2F92EE;'>#多烯紫杉醇#</a>, objectTitle=Brit J Cancer：多烯紫杉醇结合Aneustat治疗能够强烈的抑制晚期前列腺癌的转移, objectType=article, longId=130109, objectId=e11b13010935, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e11b13010935, replyNumber=0, likeNumber=107, createdTime=2018-02-15, rootId=0, userName=zhangmingxiang, userId=63eb3265522, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e11b13010935, moduleTitle=Brit J Cancer：多烯紫杉醇结合Aneustat治疗能够强烈的抑制晚期前列腺癌的转移, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=e11b13010935)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417353, encodeId=6295141e353ea, content=<a href='/topic/show?id=28ca43332b5' target=_blank style='color:#2F92EE;'>#多烯紫杉醇#</a>, objectTitle=Cancer Lett：卡巴他赛聚合物纳米粒子可以用来治疗多烯紫杉醇抗性和骨转运前列腺癌, objectType=article, longId=116011, objectId=619a116011d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=619a116011d2, replyNumber=0, likeNumber=96, createdTime=2017-10-14, rootId=0, userName=zhangmingxiang, userId=63eb3265522, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=619a116011d2, moduleTitle=Cancer Lett：卡巴他赛聚合物纳米粒子可以用来治疗多烯紫杉醇抗性和骨转运前列腺癌, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=619a116011d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417352, encodeId=5571141e35250, content=<a href='/topic/show?id=28ca43332b5' target=_blank style='color:#2F92EE;'>#多烯紫杉醇#</a>, objectTitle=BMC Urol：亚洲前列腺癌双周、减少剂量多烯紫杉醇的回顾可行性研究, objectType=article, longId=111828, objectId=0acf111828e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0acf111828e1, replyNumber=0, likeNumber=137, createdTime=2017-09-05, rootId=0, userName=zhangmingxiang, userId=63eb3265522, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0acf111828e1, moduleTitle=BMC Urol：亚洲前列腺癌双周、减少剂量多烯紫杉醇的回顾可行性研究, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=0acf111828e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417351, encodeId=dafe141e351f8, content=<a href='/topic/show?id=28ca43332b5' target=_blank style='color:#2F92EE;'>#多烯紫杉醇#</a>, objectTitle=Oncol Rep：钙蛋白酶和AR-V7是两个潜在的在去雄抵抗性前列腺癌细胞中，克服获得性多烯紫杉醇抗性治疗靶点, objectType=article, longId=99316, objectId=e9729931628, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9729931628, replyNumber=0, likeNumber=132, createdTime=2017-05-23, rootId=0, userName=zhangmingxiang, userId=63eb3265522, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9729931628, moduleTitle=Oncol Rep：钙蛋白酶和AR-V7是两个潜在的在去雄抵抗性前列腺癌细胞中，克服获得性多烯紫杉醇抗性治疗靶点, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=e9729931628)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417350, encodeId=8ed9141e350fa, content=<a href='/topic/show?id=28ca43332b5' target=_blank style='color:#2F92EE;'>#多烯紫杉醇#</a>, objectTitle=ASCO 2013：研究者推荐在亚裔晚期非小细胞肺癌患者中应用60mg/m2多烯紫杉醇治疗, objectType=article, longId=19046, objectId=9ece190461b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ece190461b, replyNumber=0, likeNumber=89, createdTime=2013-05-23, rootId=0, userName=zhangmingxiang, userId=63eb3265522, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ece190461b, moduleTitle=ASCO 2013：研究者推荐在亚裔晚期非小细胞肺癌患者中应用60mg/m2多烯紫杉醇治疗, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=9ece190461b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417349, encodeId=400b141e349f9, content=<a href='/topic/show?id=28ca43332b5' target=_blank style='color:#2F92EE;'>#多烯紫杉醇#</a>, objectTitle=Lancet Oncol：帕妥珠单抗、曲妥珠单抗和多烯紫杉醇方案可作为HER2阳性的转移性乳腺癌患者的标准治疗方案, objectType=article, longId=18507, objectId=75c41850e4b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75c41850e4b, replyNumber=0, likeNumber=68, createdTime=2013-05-11, rootId=0, userName=zhangmingxiang, userId=63eb3265522, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75c41850e4b, moduleTitle=Lancet Oncol：帕妥珠单抗、曲妥珠单抗和多烯紫杉醇方案可作为HER2阳性的转移性乳腺癌患者的标准治疗方案, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=75c41850e4b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

多烯紫杉醇

2020-05-29

zhangmingxiang (审核中...)

前往app查看评论内容

#多烯紫杉醇#

Prostate Cancer：纳米体多烯紫杉醇脂悬液在转移去势抵抗性前列腺癌中的多中心、回顾性疗效和安全性研究

2021-01-14

zhangmingxiang (审核中...)

前往app查看评论内容

#多烯紫杉醇#

Brit J Cancer：雄激素受体信号削弱了多烯紫杉醇的疗效

2020-10-17

zhangmingxiang (审核中...)

前往app查看评论内容

#多烯紫杉醇#

Cancer Immunol Immunother：混合多肽疫苗组合多烯紫杉醇和地塞米松治疗去势抵抗性前列腺癌研究

2020-02-21

zhangmingxiang (审核中...)

前往app查看评论内容

#多烯紫杉醇#

Cell Death & Differentiation：去泛素化酶USP33能够抑制多烯紫杉醇诱导的细胞凋亡

2020-01-02

zhangmingxiang (审核中...)

前往app查看评论内容

#多烯紫杉醇#

Brit J Cancer：重定位筛选鉴定了甲苯咪唑可作为临床候选药物协同多烯紫杉醇治疗前列腺癌

2020-01-01

zhangmingxiang (审核中...)

前往app查看评论内容

#多烯紫杉醇#

Oncogene：拮抗剂贝沙罗汀靶向TR4核受体能够增加前列腺癌对多烯紫杉醇的敏感性

2019-12-06

zhangmingxiang (审核中...)

前往app查看评论内容

#多烯紫杉醇#

Ann Oncol：在低和高负担转移激素敏感性前列腺癌的激素治疗中加入多烯紫杉醇效果研究

2019-11-06

zhangmingxiang (审核中...)

前往app查看评论内容

#多烯紫杉醇#

Prostate Cancer P D：去势敏感性前列腺癌中醋酸阿比特龙与多烯紫杉醇治疗成本效益分析

2019-07-21

zhangmingxiang (审核中...)

前往app查看评论内容

#多烯紫杉醇#

Prostate：靶向POH1能够抑制前列腺癌细胞生长和增强雄激素阻断治疗以多烯紫杉醇的抑制效果

2019-06-30

zhangmingxiang (审核中...)

前往app查看评论内容

#多烯紫杉醇#

J Clin Oncol：转移去势难治性前列腺癌黑人和白人患者中，多烯紫杉醇治疗总生存率研究

2019-01-06

zhangmingxiang (审核中...)

前往app查看评论内容

#多烯紫杉醇#

Brit J Cancer：Apatorsen与多烯紫杉醇结合治疗与多烯紫杉醇单独治疗铂抵抗性转移尿路上皮癌的比较研究

2018-06-10

zhangmingxiang (审核中...)

前往app查看评论内容

#多烯紫杉醇#

BJU Int：去势难治性前列腺癌（CRPC）患者中，间断性多烯紫杉醇治疗与持续性多烯紫杉醇治疗比较

2018-04-25

zhangmingxiang (审核中...)

前往app查看评论内容

#多烯紫杉醇#

Brit J Cancer：多烯紫杉醇结合Aneustat治疗能够强烈的抑制晚期前列腺癌的转移

2018-02-15

zhangmingxiang (审核中...)

前往app查看评论内容

#多烯紫杉醇#

Cancer Lett：卡巴他赛聚合物纳米粒子可以用来治疗多烯紫杉醇抗性和骨转运前列腺癌

2017-10-14

zhangmingxiang (审核中...)

前往app查看评论内容

#多烯紫杉醇#

BMC Urol：亚洲前列腺癌双周、减少剂量多烯紫杉醇的回顾可行性研究

2017-09-05

zhangmingxiang (审核中...)

前往app查看评论内容

#多烯紫杉醇#

Oncol Rep：钙蛋白酶和AR-V7是两个潜在的在去雄抵抗性前列腺癌细胞中，克服获得性多烯紫杉醇抗性治疗靶点

2017-05-23

zhangmingxiang (审核中...)

前往app查看评论内容

#多烯紫杉醇#

ASCO 2013：研究者推荐在亚裔晚期非小细胞肺癌患者中应用60mg/m2多烯紫杉醇治疗

2013-05-23

zhangmingxiang (审核中...)

前往app查看评论内容

#多烯紫杉醇#

Lancet Oncol：帕妥珠单抗、曲妥珠单抗和多烯紫杉醇方案可作为HER2阳性的转移性乳腺癌患者的标准治疗方案

2013-05-11

科室
- - 订阅+
  - 更多科室
工具
服务